Literature DB >> 1318199

Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability.

S N Willich1, G H Tofler, D A Brezinski, A I Schafer, J E Muller, T Michel, W S Colucci.   

Abstract

The incidence of myocardial infarction and sudden cardiac death increases in the morning, as do platelet aggregability and sympathetic activity. We considered the possibility that increased platelet aggregability in the morning was due to an increase in platelet alpha 2 adrenergic receptor number or agonist binding affinity, or to a temporal disparity between the increase in sympathetic activity that accompanies arising and the anticipated decrease in platelet high affinity alpha 2 adrenoceptors. To evaluate these possibilities, we studied eight healthy male volunteers (20-35 years) before and 1-1.5 and 3-4 h after they arose at 08.00 h and performed routine morning activities. Platelet aggregability was determined in platelet-rich plasma; alpha 2 adrenoceptor density and agonist binding affinity were determined in intact platelets and in membrane preparations using the alpha 2 selective ligand [3H]-yohimbine. The threshold concentration of epinephrine required to produce biphasic aggregation decreased (i.e. platelet aggregability increased) from 3.6 +/- 1.2 to 0.9 +/- 0.3 microM (P less than 0.05) after arising. However, alpha 2 adrenoceptor density (380 +/- 71 to 365 +/- 51 sites per platelet) and agonist binding affinity assessed simultaneously did not change after arising, suggesting that the increase in platelet aggregability is due to factors extrinsic to the platelets or to an intra-platelet mechanism distal to the receptor level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318199     DOI: 10.1093/oxfordjournals.eurheartj.a060212

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

1.  Influence of the Circadian System on Disease Severity.

Authors:  Mikhail Litinski; Frank Ajl Scheer; Steven A Shea
Journal:  Sleep Med Clin       Date:  2009-06-01

2.  Naftopidil inhibits 5-hydroxytryptamine-induced platelet aggregation and 5-hydroxytryptamine uptake in platelets of healthy volunteers.

Authors:  R Kirsten; M Breidert; K Nelson; A Heine; S Rosenkranz; B Erdeg; G Niebch; H O Borbe; M Siebert-Weigel; J Respondek
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Procoagulatory changes induced by head-up tilt test in patients with syncope: observational study.

Authors:  Artur Fedorowski; Nazim Isma; Viktor Hamrefors; Karin Strandberg; Richard Sutton
Journal:  Thromb J       Date:  2017-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.